A股異動 | 大勝達跌停創新低 實際控制人、董事長方能斌被留置
大勝達(603687.SH)封跌停板,報5.97元創上市新低價,市值32.8億元。公司昨日晚間公吿,收到實際控制人、董事長方能斌家屬的通知,方能斌被洛陽市西工區監察委員會留置、立案調查。值得注意的是,大勝達之前曾因為募投項目的延期問題受到市場關注。據不完全統計,下半年已有9家上市公司高管被採取留置措施。且從股價表現來看,這類公吿均被市場解讀為較大利空,如威士頓公吿次日股價“20cm”跌停,雪榕生物公吿次日股價大跌8%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.